Control of infective complications of transrectal prostate biopsy

Surgical Infections

Volumn 15, Issue 4, 2014, Pages 431-436

  Park, Dong Soo ^a   Hwang, Jin Ho ^a   Choi, Don Kyung ^a   Gong, In Hyuck ^a   Hong, Young Kwon ^a   Park, Sujin ^b   Oh, Jong Jin ^c  

^a CHA University   (South Korea)

^b CHA Cancer Research Center   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEPHALOSPORIN; ENEMA; POVIDONE IODINE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BIOPSY NEEDLE; CANCER DIAGNOSIS; CONTROLLED STUDY; EPIDIDYMITIS; FAINTNESS; FEVER; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; INFECTION CONTROL; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; ORCHITIS; PERINEAL PAIN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATITIS; PYURIA; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SEPSIS; SINGLE DRUG DOSE; SUPPOSITORY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; ULTRASOUND SCANNER; URINARY TRACT INFECTION; URINE RETENTION; ADVERSE EFFECTS; BACTERIAL INFECTIONS; CHEMOPROPHYLAXIS; MIDDLE AGED; NEEDLE BIOPSY; PREOPERATIVE CARE; PROCEDURES; PROSTATIC DISEASES; TEMPERATURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOPSY, NEEDLE; CEPHALOSPORINS; CHEMOPREVENTION; HUMANS; MALE; MIDDLE AGED; POVIDONE-IODINE; PREOPERATIVE CARE; PROSTATIC DISEASES; RETROSPECTIVE STUDIES; TEMPERATURE; TREATMENT OUTCOME;

EID: 84906282083     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2013.138     Document Type: Article

References (30)

1. Akduman B, Akduman D, Tokgoz H, et al. Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 2011;78:250-255.
2. Jeon SS,Woo SH, Hyun JH, et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound- guided prostate biopsy. Urology 2003; 62:461-466.
3. Carlson WH, Bell DG, Lawen JG, et al. Multi-drug resistant E. coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies-Three cases including one death. Can J Urol 2010;17:5135-137.
4. Shandera KC, Thibault GP, Deshon GE, Jr. Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 1998; 52:641-643.
5. Sieber PR, Rommel FM, Agusta VE, et al. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997;157:2199-2200.
6. Rietbergen JB, Kruger AE, Kranse R, et al. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875-880.
7. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int 2000;85:682-685.
8. Kapoor DA, Klimberg IW, Malek GH, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-558.
9. Tal R, Livne PM, Lask DM, et al. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003;169:1762-1765.
10. Aus G, Ahlgren G, Bergdahl S, et al. Infection after transrectal core biopsies of the prostate-Risk factors and antibiotic prophylaxis. Br J Urol 1996;77:851-855.
11. Brown RW, Warner JJ, Turner BI, et al. Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 1981; 18:145-148.
12. Melekos MD. Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 1990;22:257-262.
13. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
14. Lee G, Attar K, Laniado M, et al. Trans-rectal ultrasound guided biopsy of the prostate: Nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 2007;39:185-188.
15. Patel U, Kirby R. Infections after prostate biopsy and antibiotic resistance. BJU Int 2008;101:1201-1202.
16. Hoshi A, Nitta M, Hongoh S, et al. [Sepsis following transrectal prostate biopsy: a report of 2 cases and reviewed similar cases in Japan]. Hinyokika Kiyo 2006;52:645-649.
17. Batura D, Rao GG, Bo Nielsen P, et al. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 2011;107:760-764.
18. Mosharafa AA, Torky MH, El Said WM, et al. Rising incidence of acute prostatitis following prostate biopsy: Fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011;78:511-514.
19. Hori S, Sengupta A, Joannides A, et al. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: Are we putting our patients at risk? BJU Int 2010;106:1298-1302.
20. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy- Are fluoroquinolones still effective prophylaxis? J Urol 2008;179:952-955.
21. Kim ME, Ha US, Cho YH. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: A multicentre study in 2006. Int J Antimicrob Agents 2008; 31:S15-18.
22. Liss MA, Chang A, Santos R, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 2011;185:1283-1288.
23. Davis M, Sofer M, Kim SS, et al. The procedure of transrectal ultrasound guided biopsy of the prostate: A survey of patient preparation and biopsy technique. J Urol 2002;167: 566-570.
24. Zaytoun OM, Anil T, Moussa AS, et al. Morbidity of prostate biopsy after simplified versus complex preparation protocols: Assessment of risk factors. Urology 2011;77: 910-914.
25. Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 2001;166:82-85.
26. Ruddick F, Sanders P, Bicknell SG, et al. Sepsis rates after ultrasound-guided prostate biopsy using a bowel preparation protocol in a community hospital. J Ultrasound Med 2011;30:213-216.
27. Huang YC, Ho DR, Wu CF, et al. Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J 2006;29:395-400.
28. Shiraishi T, Oka R, Nakagawa Y. Pharmaceutical and bacteriological study on povidone-iodine sugar ointment. Dermatology 1997;195:100-103.
29. Park DS, Oh JJ, Lee JH, et al. Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol 2009;750598.
30. Carignan A, Roussy JF, Lapointe V, et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: Time to reassess antimicrobial prophylaxis? Eur Urol 2012;62:453-459.